OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

OrganiGram Holdings Inc.TSX: OGI.TO

Revenue · Q2 FY2026 · quarter ended Mar 2026

Revenue dips below year-ago levels

Q2 FY2026 revenue of CA$59.79M fell 8.9% year over year, behind the +41.3% change in trailing-twelve-month revenue. Sequentially, it fell 5.9% from the prior quarter.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 4 analysts of CA$349.69M (+34.9%) for the fiscal year ending Sep 2026, a slowdown from the +62.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$59.79M-5.9% QoQ
Last fiscal yearSep 2025
CA$259.18M+62.2% YoY
LTMMar 2026
CA$274.19M+41.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.9%+36.8%+45.7 pp
1 year+62.2%+34.9%-27.2 pp
3-year CAGR—+23.3%—
5-year CAGR+16.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2025
259.18M CAD
Year-over-year change
+62.2%
4-year CAGR
+34.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +41.3% is the 2nd highest of 9, against a peer median of +7.9%.
OGI.TO Competitors
Revenue for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$318.43M CAD-7.2%+11.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$310.92M CAD+15.6%-5.1%
DR.TOMedical Facilities CorporationLTM Mar 2026$305.39M USD+0.1%-15.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$274.19M CAD+41.3%—
TSND.TOTerrAscend Corp.LTM Mar 2026$261.74M USD-8.7%+3.3%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$158.57M CAD+22.2%+17.0%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$55.76M USD-1.8%-2.8%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$51.17M USD+65.5%+207.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$50.92M USD+28.9%+35.4%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 USD——
Peer median (excluding OGI.TO) —+7.9%+7.2%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.